# Knight-Swift Transportation Holdings Inc.: financial statements, quarterly

KNX · NYSE · CIK 1492691 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/knx.md) · [Financials](/companies/knx/financials.md) · [Filings](/companies/knx/filings.md) · [Insiders](/companies/knx/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/knx/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,553](/filings/0001492691-24-000080.md) | [2,020](/filings/0001492691-24-000091.md) | [1,932 d](/filings/0001492691-26-000016.md) | [1,822](/filings/0001492691-25-000042.md) | [1,847](/filings/0001492691-25-000060.md) | [1,877](/filings/0001492691-25-000074.md) | [1,864 d](/filings/0001492691-26-000016.md) | [1,824](/filings/0001492691-26-000038.md) | [1,862](/filings/0001492691-25-000060.md) | [1,927](/filings/0001492691-25-000074.md) | [1,856 d](/filings/0001492691-26-000016.md) | [1,850](/filings/0001492691-26-000038.md) |
| Operating income | $m | [94.0](/filings/0001492691-24-000080.md) | [81.1](/filings/0001492691-24-000091.md) | [18.3 d](/filings/0001492691-26-000016.md) | [20.6](/filings/0001492691-25-000042.md) | [63.5](/filings/0001492691-25-000060.md) | [81.4](/filings/0001492691-25-000074.md) | [78.0 d](/filings/0001492691-26-000016.md) | [66.7](/filings/0001492691-26-000038.md) | [72.6](/filings/0001492691-25-000060.md) | [50.3](/filings/0001492691-25-000074.md) | [26.5 d](/filings/0001492691-26-000016.md) | [28.6](/filings/0001492691-26-000038.md) |
| Interest expense | $m | [24.4](/filings/0001492691-24-000080.md) | [39.4](/filings/0001492691-23-000093.md) | [40.3 d](/filings/0001492691-24-000015.md) | [41.2](/filings/0001492691-24-000064.md) | [40.5](/filings/0001492691-24-000080.md) | [44.4](/filings/0001492691-25-000074.md) | [45.0 d](/filings/0001492691-26-000016.md) | [40.2](/filings/0001492691-26-000038.md) | [40.9](/filings/0001492691-25-000060.md) | [40.9](/filings/0001492691-25-000074.md) | [39.8 d](/filings/0001492691-26-000016.md) | [30.7](/filings/0001492691-26-000038.md) |
| Income tax | $m | [22.0](/filings/0001492691-24-000080.md) | [(1.2)](/filings/0001492691-24-000091.md) | [1.3 d](/filings/0001492691-26-000016.md) | [(3.7)](/filings/0001492691-25-000042.md) | [11.8](/filings/0001492691-25-000060.md) | [14.1](/filings/0001492691-25-000074.md) | [10.7 d](/filings/0001492691-26-000016.md) | [10.3](/filings/0001492691-26-000038.md) | [14.0](/filings/0001492691-25-000060.md) | [7.4](/filings/0001492691-25-000074.md) | [(1.9) d](/filings/0001492691-26-000016.md) | [(0.1)](/filings/0001492691-26-000038.md) |
| Net income | $m | [63.3](/filings/0001492691-24-000080.md) | [60.2](/filings/0001492691-24-000091.md) | [(10.7) d](/filings/0001492691-26-000016.md) | [(2.6)](/filings/0001492691-25-000042.md) | [20.3](/filings/0001492691-25-000060.md) | [30.5](/filings/0001492691-25-000074.md) | [69.5 d](/filings/0001492691-26-000016.md) | [30.6](/filings/0001492691-26-000038.md) | [34.2](/filings/0001492691-25-000060.md) | [7.9](/filings/0001492691-25-000074.md) | [(6.8) d](/filings/0001492691-26-000016.md) | [(1.3)](/filings/0001492691-26-000038.md) |
| Diluted EPS | $ per share | [0.39](/filings/0001492691-24-000080.md) | [0.37](/filings/0001492691-24-000091.md) | not reported | [(0.02)](/filings/0001492691-25-000042.md) | [0.13](/filings/0001492691-25-000060.md) | [0.19](/filings/0001492691-25-000074.md) | not reported | [0.19](/filings/0001492691-26-000038.md) | [0.21](/filings/0001492691-25-000060.md) | [0.05](/filings/0001492691-25-000074.md) | not reported | [(0.01)](/filings/0001492691-26-000038.md) |
| Basic EPS | $ per share | [0.39](/filings/0001492691-24-000080.md) | [0.37](/filings/0001492691-24-000091.md) | not reported | [(0.02)](/filings/0001492691-25-000042.md) | [0.13](/filings/0001492691-25-000060.md) | [0.19](/filings/0001492691-25-000074.md) | not reported | [0.19](/filings/0001492691-26-000038.md) | [0.21](/filings/0001492691-25-000060.md) | [0.05](/filings/0001492691-25-000074.md) | not reported | [(0.01)](/filings/0001492691-26-000038.md) |

- Revenue: us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.2](/filings/0001492691-24-000080.md) | [0.2](/filings/0001492691-24-000091.md) | [0.2](/filings/0001492691-26-000016.md) | [0.2](/filings/0001492691-25-000042.md) | [0.2](/filings/0001492691-25-000060.md) | [0.2](/filings/0001492691-25-000074.md) | [0.2](/filings/0001492691-26-000038.md) | [0.2](/filings/0001492691-26-000038.md) | [0.2](/filings/0001492691-25-000060.md) | [0.2](/filings/0001492691-25-000074.md) | [0.2](/filings/0001492691-26-000038.md) | [0.2](/filings/0001492691-26-000038.md) |
| Current assets | $bn | [1.9](/filings/0001492691-23-000076.md) | [1.8](/filings/0001492691-23-000093.md) | [1.7](/filings/0001492691-25-000013.md) | [1.5](/filings/0001492691-24-000064.md) | [1.5](/filings/0001492691-24-000080.md) | [1.4](/filings/0001492691-24-000091.md) | [1.4](/filings/0001492691-26-000016.md) | [1.5](/filings/0001492691-25-000042.md) | [1.4](/filings/0001492691-25-000060.md) | [1.5](/filings/0001492691-25-000074.md) | [0.9](/filings/0001492691-26-000038.md) | [1.0](/filings/0001492691-26-000038.md) |
| Total assets | $bn | [11.4](/filings/0001492691-23-000076.md) | [12.8](/filings/0001492691-23-000093.md) | [12.9](/filings/0001492691-25-000013.md) | [12.6](/filings/0001492691-24-000064.md) | [12.6](/filings/0001492691-24-000080.md) | [12.8](/filings/0001492691-24-000091.md) | [12.7](/filings/0001492691-26-000016.md) | [12.6](/filings/0001492691-25-000042.md) | [12.5](/filings/0001492691-25-000060.md) | [12.6](/filings/0001492691-25-000074.md) | [12.0](/filings/0001492691-26-000038.md) | [11.9](/filings/0001492691-26-000038.md) |
| Current liabilities | $bn | [0.9](/filings/0001492691-23-000076.md) | [1.7](/filings/0001492691-23-000093.md) | [1.8](/filings/0001492691-25-000013.md) | [1.6](/filings/0001492691-24-000064.md) | [1.7](/filings/0001492691-24-000080.md) | [1.4](/filings/0001492691-24-000091.md) | [1.7](/filings/0001492691-26-000016.md) | [1.6](/filings/0001492691-25-000042.md) | [1.6](/filings/0001492691-25-000060.md) | [1.1](/filings/0001492691-25-000074.md) | [1.0](/filings/0001492691-26-000038.md) | [1.4](/filings/0001492691-26-000038.md) |
| Total liabilities | $bn | [4.4](/filings/0001492691-23-000076.md) | [5.7](/filings/0001492691-23-000093.md) | [5.8](/filings/0001492691-25-000013.md) | [5.6](/filings/0001492691-24-000064.md) | [5.5](/filings/0001492691-24-000080.md) | [5.8](/filings/0001492691-24-000091.md) | [5.6](/filings/0001492691-26-000016.md) | [5.5](/filings/0001492691-25-000042.md) | [5.4](/filings/0001492691-25-000060.md) | [5.5](/filings/0001492691-25-000074.md) | [4.9](/filings/0001492691-26-000038.md) | [4.9](/filings/0001492691-26-000038.md) |
| Long-term debt | $bn | [1.5](/filings/0001492691-23-000076.md) | [1.9](/filings/0001492691-23-000093.md) | [1.6](/filings/0001492691-25-000013.md) | [1.7](/filings/0001492691-24-000064.md) | [1.6](/filings/0001492691-24-000080.md) | [1.9](/filings/0001492691-24-000091.md) | [1.8](/filings/0001492691-26-000016.md) | [1.8](/filings/0001492691-25-000042.md) | [1.8](/filings/0001492691-25-000060.md) | [1.9](/filings/0001492691-25-000074.md) | [1.7](/filings/0001492691-26-000038.md) | [1.8](/filings/0001492691-26-000038.md) |
| Current portion of debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [7.1](/filings/0001492691-23-000076.md) | [7.1](/filings/0001492691-23-000093.md) | [7.1](/filings/0001492691-25-000013.md) | [7.1](/filings/0001492691-24-000064.md) | [7.1](/filings/0001492691-24-000080.md) | [7.1](/filings/0001492691-24-000091.md) | [7.1](/filings/0001492691-26-000016.md) | [7.1](/filings/0001492691-25-000042.md) | [7.1](/filings/0001492691-25-000060.md) | [7.1](/filings/0001492691-25-000074.md) | [7.1](/filings/0001492691-26-000038.md) | [7.1](/filings/0001492691-26-000038.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [377 d](/filings/0001492691-24-000080.md) | [151 d](/filings/0001492691-24-000091.md) | [288 d](/filings/0001492691-26-000016.md) | [37.3](/filings/0001492691-25-000042.md) | [273 d](/filings/0001492691-25-000060.md) | [214 d](/filings/0001492691-25-000074.md) | [274 d](/filings/0001492691-26-000016.md) | [109](/filings/0001492691-26-000038.md) | [217 d](/filings/0001492691-25-000060.md) | [218 d](/filings/0001492691-25-000074.md) | [723 d](/filings/0001492691-26-000016.md) | [143](/filings/0001492691-26-000038.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [23.0 d](/filings/0001492691-24-000080.md) | [22.6 d](/filings/0001492691-24-000091.md) | [22.6 d](/filings/0001492691-26-000016.md) | [25.9](/filings/0001492691-25-000042.md) | [26.4 d](/filings/0001492691-25-000060.md) | [25.9 d](/filings/0001492691-25-000074.md) | [25.9 d](/filings/0001492691-26-000016.md) | [29.3](/filings/0001492691-26-000038.md) | [29.7 d](/filings/0001492691-25-000060.md) | [29.2 d](/filings/0001492691-25-000074.md) | [29.2 d](/filings/0001492691-26-000016.md) | [32.7](/filings/0001492691-26-000038.md) |
| Share repurchases | $m | [0.0 d](/filings/0001492691-23-000076.md) | [0.0 d](/filings/0001492691-23-000093.md) | [0.0 d](/filings/0001492691-25-000013.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [163](/filings/0001492691-23-000076.md) | [162](/filings/0001492691-23-000093.md) | [162](/filings/0001492691-24-000064.md) | [162](/filings/0001492691-24-000080.md) | [162](/filings/0001492691-24-000091.md) | [162](/filings/0001492691-25-000042.md) | [162](/filings/0001492691-25-000060.md) | [162](/filings/0001492691-25-000074.md) | [162](/filings/0001492691-26-000038.md) | [163](/filings/0001492691-25-000060.md) | [163](/filings/0001492691-25-000074.md) | [163](/filings/0001492691-26-000038.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 162,494,000 at 2026-04-22, from the cover of the [10-Q filed 2026-04-29](/filings/0001492691-26-000038.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.